|
Sunwin International Neutraceuticals
in Distribution Pact With Turkish Company
Aug.04, 2007
Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader
in the production and distribution of Chinese herbs, veterinary
medicines and one of the largest producers of the low calorie
sweetener (Stevia) in China, announced today it has entered into a
distribution agreement with Agra Uluslararasi ticeret Ltd. ("Agra"),
a distribution company doing business in the Turkish Nation.
Under the terms of the agreement Sunwin will allow Agra to be the
exclusive distributor of its stevia-based products as well as
certain herb-based medicines throughout Turkey. The agreement is
part of Sunwin's plan to increase its distribution capabilities on a
global basis for its ramping production capacity. Sunwin intends to
continue to aggressively seek partners in distribution for various
places throughout the world and anticipates reaching similar
agreements with other distributors in the coming quarters.
Laiwang Zhang, President and Chairman of Sunwin International
Neutraceuticals, commented, "We are happy to work with Agra and
count them among our growing list of distribution partners. We have
focused on building capacity and product depth in our fiscal 2007
year and we now look to capitalize on the growing worldwide demand
for our products. This agreement is another step in our global
distribution plans."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) is engaged
in the areas of essential traditional Chinese medicine, low-calorie
natural sweetener (Stevia), and veterinary medicines and feeds
prepared from 100% organic herbal ingredients. As an industry leader
in agricultural processing, Sunwin has built an integrated global
firm with the sourcing and production capabilities to meet the needs
of consumers throughout the world. Sunwin also makes such
value-added products as specialty veterinary food ingredients and
specialty feed ingredients. For more info about Sunwin, please visit
http://www.sunwin.biz.
Safe Harbor Statement
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on current expectations
or beliefs, including, but not limited to, statements concerning the
Company's operations, financial performance and, condition. For this
purpose, statements that are not statements of historical fact may
be deemed to be forward-looking statements. The Company cautions
that these statements by their nature involve risks and
uncertainties, and actual results may differ materially depending on
a variety of important factors, including, but not limited to, the
impact of competitive products, pricing and new technology; changes
in consumer preferences and tastes; and effectiveness of marketing;
changes in laws and regulations; fluctuations in costs of
production, and other factors as those discussed in the Company's
reports filed with the Securities and Exchange Commission from time
to time. In addition, the company disclaims any obligation to update
any forward-looking statements to reflect events or circumstances
after the date hereof.
Contact:
Sunwin International Neutraceuticals, Inc.
Phone: 1-877-China-57
Email: info@sunwin.biz
|
